• 1
    Cooper RG, Freemont AJ. TNF-α blockade for herniated intervertebral disc-induced sciatica: way forward at last? Rheumatology 2004; 43: 11921.
  • 2
    Goupille P, Mulleman D, Valat JP. Radiculopathy associated with disc herniation. Ann Rheum Dis 2006; 65: 1413.
  • 3
    Mixter WJ, Barr JS. Rupture of the intervertebral disc with involvement of the spinal canal. N Engl J Med 1934; 211: 2105.
  • 4
    Loupasis GA, Stamos K, Katonis PG, Sapkas G, Korres DS, Hartofilakidis G. Seven-to 20-year outcome of lumbar discectomy. Spine 1999; 24: 23137.
  • 5
    Vik A, Zwart JA, Hulleberg G, Nygaard OP. Eight year outcome after surgery for lumbar disc herniation: a comparison of reoperated and not reoperated patients. Acta Neurochir 2001; 143: 60711.
  • 6
    Atlas SJ, Keller RB, Wu YA, Deyo RA, Singer DE. Long-term outcomes of surgical and non surgical management of sciatica secondary to a lumbar disc herniation: 10-year results from the Maine lumbar spine study. Spine 2005; 30: 92735.
  • 7
    Boden SD, Davis DO, Dina TS, Patronas NJ, Wiesel SE. Abnormal magnetic resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J Bone Joint Surg 1990; 72A: 4038.
  • 8
    Boos N, Rider R, Schade V, Spratt KF, Semmer N, Aebi M. 1995 Volvo Award in clinical sciences: the diagnostic accuracy of magnetic resonance imaging, work perception, and psychosocial factors in identifying symptomatic disc herniations. Spine 1995; 15: 261325.
  • 9
    Thelander U, Fagerlund M, Friberg S, Larsson F. Straight leg raising test versus radiologic size, shape, and position of lumbar disc herniations. Spine 1992; 17: 3959.
  • 10
    Weber H. Lumbar disc herniation: a controlled, prospective study with ten years of observation. Spine 1983; 8: 13140.
  • 11
    Olmarker K, Blomquist J, Stromberg J, Nannmark U, Thomsen P, Rydevik B. Inflammatogenic properties of nucleus pulposus. Spine 1995; 20: 6659.
  • 12
    Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 1993; 18: 142532.
  • 13
    Geiss A, Larsson K, Rydevik B, Takahashi I, Olmarker K. Autoimmune properties of nucleus pulposus: an experimental study in pigs. Spine 2007; 32: 16873.
  • 14
    Saal JA, Saal JS, Herzog RJ. The natural history of lumbar intervertebral disc extrusions treated nonoperatively. Spine 1990; 15: 6836.
  • 15
    Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 1996; 21: 2717.
  • 16
    Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS. mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine 2002; 27: 9117.
  • 17
    Goupille P, Jayson MI, Valat JP, Freemont AJ. The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum 1998; 28: 6071.
  • 18
    Kulisch SD, Ulstrom CL, Michael CJ. The tissue origin of low-back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am 1991; 22: 1817.
  • 19
    Powell HC, Myers RR. Pathology of experimental nerve root compression. Lab Invest 1986; 55: 91100.
  • 20
    Olmarker K, Storkson R, Berge OG. Pathogenesis of sciatic pain: a study of spontaneous behavior in rats exposed to experimental disc herniation. Spine 2002; 27: 13127.
  • 21
    Takahashi N, Yabuki S, Aoki Y, Kikuchi S. Pathomechanisms of nerve root injury caused by disc herniation: an experimental study of mechanical compression and chemical irritation. Spine 2003; 28: 43541.
  • 22
    Kawakami M, Hashizume H, Nishi H, Matsumoto T, Tamaki T, Kuribayashi K. Comparison of neuropathic pain induced by the application of normal and mechanically compressed nucleus pulposus to lumbar nerve roots in the rat. J Orthop Res 2003; 21: 5359.
  • 23
    Hou SX, Tang JG, Chen HS, Chen J. Chronic inflammation and compression of the dorsal root contribute to sciatica induced by the intervertebral disc herniation in rats. Pain 2003; 105: 25564.
  • 24
    Olmarker K, Myers RR. Pathogenesis of sciatic pain: role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain 1998; 78: 99105.
  • 25
    Olmarker K, Byrod G, Cornefjord M, Nordborg C, Rydevik B. Effects of methylprednisolone on nucleus pulposus-induced nerve root injury. Spine 1994; 19: 18038.
  • 26
    Cornefjord M, Olmarker K, Otani K, Rydevik B. Nucleus pulposus-induced nerve root injury: effects of diclofenac and ketoprofen. Eur Spine J 2002; 11: 5761.
  • 27
    Arai I, Mao GP, Otani K, Kono S, Kikuchi S, Olmarker K. Indomethacin blocks the nucleus pulposus-induced effects on nerve root function: an experimental study in dogs with assessment of nerve conduction and blood flow following experimental disc herniation. Eur Spine J 2004; 13: 6914.
  • 28
    Olmarker K, Brisby H, Yabuki S, Nordborg C, Rydevik B. The effects of normal, frozen, and hyaluronidase-digested nucleus pulposus on nerve root structure and function. Spine 1997; 22: 4715.
  • 29
    Olmarker K, Nordborg C, Larsson K, Rydevik B. Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine 1996; 21: 4114.
  • 30
    Yabuki S, Kikuchi S, Olmarker K, Myers RR. Acute effects of nucleus pulposus on blood flow and endoneurial fluid pressure in rat dorsal root ganglia. Spine 1998; 23: 251723.
  • 31
    Otani K, Arai I, Mao GP, Konno S, Olmarker K, Kikuchi S. Nucleus pulposus-induced nerve root injury: relationship between blood flow and motor nerve conduction velocity. Neurosurgery 1999; 45: 6149.
  • 32
    Wagner R, Myers RR. Endoneurial injection of TNF-α produces neuropathic pain behaviors. Neuroreport 1996; 7: 2897901.
  • 33
    Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelinisation induced by the intraneural injection of tumour necrosis factor. Brain 1995; 118: 86978.
  • 34
    Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996; 10: 8190.
  • 35
    Smith CS, Ortega G, Parker L, Shearer WT. Cyclosporin A blocks induction of tumour necrosis factor-α in human B lymphocytes. Biochem Biophys Res Commun 1994; 204: 38390.
  • 36
    Garcia-Vicuna R, Diaz-Gonzales F, Gonzales-Alvaro I, del Pozo MA, Mollinedo F, Cabanas C, et al. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. Arthritis Rheum 1997; 40: 14353.
  • 37
    Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumor necrosis factor-α induces ectopic activity in nociceptive primary afferents fibers. Neuroscience 1997; 81: 25562.
  • 38
    Shapira L, Youri Y, Barak V, Soskolne WA, Halabi A, Stabholz A. Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNFα processing in vitro. J Periodontal Res 1997; 32: 1838.
  • 39
    Olmarker K, Larsson K. Tumor necrosis factor α and nucleus-pulposus-induced nerve root injury. Spine 1998; 23: 253844.
  • 40
    Clatworthy AL, Illich PA, Castro GA, Walters ET. Role of periaxonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett 1995; 184: 58.
  • 41
    Myers RR, Wagner R, Sorkin LS. Hyperalgesic actions of cytokines on peripheral nerves. In: WatkinsLR, MaierSF, editors. Cytokines and pain. Basel (Switzerland); Boston: Birkhauser Verlag 1999. p. 13357.
  • 42
    Wells MR, Racis SP Jr, Vaidya U. Changes in plasma cytokines associated with peripheral nerve injury. J Neuroimmunol 1992; 39: 2618.
  • 43
    Sommer C, Schmidt C, George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998; 151: 13842.
  • 44
    Schafers M, Lee DH, Brors D, Yaksh TL, Sorkin LS. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-α after spinal nerve ligation. J Neurosci 2003; 23: 302838.
  • 45
    Homma Y, Brull SJ, Zhang JM. A comparison of chronic pain behavior following local application of tumor necrosis factor-α to the normal, mechanically compressed lumbar ganglia in the rat. Pain 2002; 95: 23946.
  • 46
    Sommer C, Marziniak M, Myers RR. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 1998; 74: 8391.
  • 47
    Watkins L, Goehler L, Rekton J, Brewer M, Maier S. Mechanisms of tumor necrosis factor-α (TNF-α) hyperalgesia. Brain Res 1995; 692: 24450.
  • 48
    Sommer C, Lindenlaub T, Teuteberg P, Schafers M, Hartung T, Toyka KV. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res 2001; 913: 869.
  • 49
    Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K. Distribution and appearance of tumor necrosis factor-α in the dorsal root ganglion exposed to experimental disc herniation in rats. Spine 2004; 29: 223541.
  • 50
    Wagner R, Myers RR. Schwann cells produce tumor necrosis factor α: expression in injured and non-injured nerves. Neuroscience 1996; 73: 6259.
  • 51
    Taskinen HS, Olsson T, Bucht A, Khademi M, Svelander L, Roytta M. Peripheral nerve injury induces endoneurial expression of IFN-γ, IL-10 and TNF-α mRNA. J Neuroimunol 2000; 102: 1725.
  • 52
    George A, Marziniak M, Schafers M, Toyka KV, Sommer C. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 2000; 88: 26775.
  • 53
    George A, Buehl A, Sommer C. Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-α protein. Neurosci Lett 2004; 372: 2159.
  • 54
    Igarashi T, Kikuchi S, Shubayev V, Myers RR. 2000 Volvo Award winner in basic science studies: exogenous tumor necrosis factor-α mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 2000; 25: 297580.
  • 55
    Aoki Y, Rydevik B, Kikuchi S, Olmarker K. Local application of disc-related cytokines on spinal nerve roots. Spine 2002; 27: 16147.
  • 56
    Olmarker K, Nutu M, Storkson R. Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-α inhibition. Spine 2003; 28: 163542.
  • 57
    Lindenlaub T, Teuteberg P, Hartung T, Sommer C. Effects of neutralizing antibodies to TNF-α on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res 2000; 866: 1522.
  • 58
    Schafers M, Brinkhoff J, Neukirchen S, Marziniak M, Sommer C. Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-α and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett 2001; 310: 1136.
  • 59
    Sommer C, Schafers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001; 6: 6772.
  • 60
    Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-α prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 2001; 26: 8639.
  • 61
    Onda A, Yabuki S, Kikuchi S. Effects of neutralizing antibodies to tumor necrosis factor-α on nucleus pulposus-induced abnormal nociresponses in rat dorsal horn neurons. Spine 2003; 28: 96772.
  • 62
    Onda A, Murata Y, Rydevik B, Larsson K, Kikuchi S, Olmarker K. Immunoreactivity of brain-derived neurotrophic factor in rat dorsal root ganglion and spinal cord dorsal horn following exposure to herniated nucleus pulposus. Neurosci Lett 2003; 352: 4952.
  • 63
    Onda A, Murata Y, Rydevik B, Larsson K, Kikuchi S, Olmarker K. Infliximab attenuates immunoreactivity of brain-derived neurotrophic factor in a rat model of herniated nucleus pulposus. Spine 2004; 29: 185761.
  • 64
    Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K. Selective inhibition of tumor necrosis factor-α prevents nucleus pulposus-induced histologic changes in the dorsal root ganglion. Spine 2004; 29: 247784.
  • 65
    Murata Y, Olmarker K, Takahashi I, Takahashi K, Rydevik B. Effect of selective tumor necrosis factor-α inhibition to pain-behavioral changes caused by nucleus pulposus-induced damage to the spinal nerve in rats. Neurosci Lett 2005; 382: 14852.
  • 66
    Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllonen E, Lindgren KA, et al. Tumor necrosis factor-α monoclonal antibody, infliximab, used to manage severe sciatica. Spine 2003; 28: 7503.
  • 67
    Fairbank JT, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy 1980; 66: 2713.
  • 68
    Roland M, Morris R. A study of natural history of back pain: development of a reliable and sensitive measure of disability in low back pain. Spine 1983; 8: 1414.
  • 69
    Genevay S, Stingelin S, Gabay C. Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann Rheum Dis 2004; 63: 11203.
  • 70
    Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Intervertebral discs which cause low back pain secrete high level of proinflammatory mediators. J Bone Joint Surg 2002; 84B: 196201.
  • 71
    Weiler C, Nerlich AG, Bachmeier BE, Boos N. Expression and distribution of tumor necrosis factor-alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine 2005; 30: 4453.
  • 72
    Steinmeyer J, Daufeldt S, Taiwo YO. Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1-treated articular cartilage. Biochem Pharmacol 1998; 55: 93100.
  • 73
    Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 1996; 93: 140149.
  • 74
    Hattori A, Iwasaki S, Murase K, Tsujimoto M, Sato M, Hayashi K, et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-γ in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994; 340: 17780.
  • 75
    Larsson K, Rydevik B, Olmarker K. Disc related cytokines inhibit axonal outgrowth from dorsal root ganglion cells in vitro. Spine 2005; 30: 6214.
  • 76
    Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 1998; 85: 110.
  • 77
    Schafers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003; 23: 251721.
  • 78
    Sasaki N, Kikuchi SI, Konno SI, Sekiguchi M, Watanabe K. Anti-TNF-α antibody reduces pain-behavioral changes induced by epidural application of nucleus pulposus in a rat model depending on the timing of administration. Spine 2007; 32: 4136.
  • 79
    Xu JT, Xin WJ, Zang Y, Wu CY, Liu XG. The role of tumor necrosis factor-α in the neuropathic pain induced by lumbar 5 ventral root transaction in rat. Pain 2006; 123: 30621.
  • 80
    Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Jarvinen S, et al. The treatment of disc herniation-induced sciatica with infliximab: results of a randomised, controlled, 3-month follow-up study. Spine 2005; 30: 27248.
  • 81
    Korhonen T, Karppinen J, Paimela L, Malmivaara A, Lindgren KA, Bowman C, et al. The treatment of disc herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine 2006; 31: 275966.
  • 82
    Autio RA, Karppinen J, Niinimaki J, Ojala R, Veeger N, Korhonen T, et al. The effect of infliximab, a monoclonal antibody against TNF-α on disc herniation resoprtion: a randomized controlled trial. Spine 2006; 31: 26415.
  • 83
    Carragee EJ, Klapper JA, Schaufele MK, Karppinen J, Levine J, Shabe P, et al. Oral REN-1654 in sciatica: a phase 2, randomized, double-blind, placebo-controlled, multicenter study in subjects with pain due to lumbosacral radiculopathy [abstract]. Spine J 2006; 6: 2S.
  • 84
    Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 227585.
  • 85
    Okada SK, Siegel NJ. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. JAMA 2006; 296: 22012.
  • 86
    Dixon W, Silman A. Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al. Arthritis Res Ther 2006; 8: 111.
  • 87
    Curtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists. Arthritis Rheum 2007; 56: 112533.
  • 88
    Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005; 52: 340312.